In a report published Monday, Canaccord Genuity reiterated its Buy rating on SunOpta STKL, and slightly raised its price target from $7.50 to $8.50.
Canaccord Genuity noted, “We continue to believe that SunOpta's focus on natural and organic products will deliver favorable growth with earnings further benefitting from a refocusing on its core food platforms. California's Prop 37 ballot initiative requiring the labeling of genetically modified foods looks likely to pass as a recent poll shows Californians support the measure roughly 3 to 1. SunOpta is best positioned to see an almost immediate business acceleration as we expect the food industry to respond with attempts to reformulate some of its offerings as non-GMO in order to avoid mandatory labeling.”
SunOpta closed on Friday at $6.69.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in